Electroconvulsive Therapy in Complex Regional Pain Syndromes

Journal of ECT

Volumn 19, Issue 4, 2003, Pages 226-229

  McDaniel, William W ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Complex regional pain syndrome; CRPS; Depression; ECT; Fibromyalgia

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; FLUOXETINE; METHYLPHENIDATE; PAROXETINE; QUETIAPINE; VALPROATE SEMISODIUM;

AGED; ARTICLE; CASE REPORT; CHRONIC PAIN; CLINICAL FEATURE; COMORBIDITY; COMPLEX REGIONAL PAIN SYNDROME; DEPRESSION; DISEASE COURSE; ELECTROCONVULSIVE THERAPY; FEMALE; FIBROMYALGIA; HUMAN; MALE; NEUROTRANSMISSION; REVIEW; SEIZURE; TREATMENT OUTCOME;

ADULT; COMPLEX REGIONAL PAIN SYNDROMES; DEPRESSIVE DISORDER; ELECTROCONVULSIVE THERAPY; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; SEIZURES; TREATMENT OUTCOME;

EID: 0347511825     PISSN: 10950680     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124509-200312000-00009     Document Type: Article

References (24)

1. Bradley JJ. Severe localized pain associated with the depressive syndrome. Br J Psychiatry. 1963;109: 741-745.
2. Baron R, Wasner G. Complex regional pain syndrome. Curr Headache Pain Rep. 2001;5:114-123.
3. Parker G, Roy K, Wilhelm K, et al. Assessing the comparative effectiveness of antidepressant therapies: a prospective clinical practice study. J Clin Psychiatry. 2001;62:117-125.
4. Sackeim HA. the antidepressant efficacy of high-dose nondominant long-distance parietotemporal and bitemporal electroconvulsive therapy. Convuls Ther. 1994;10:43-52.
5. King JH, Nuss S. Reflex sympathetic dystrophy treated by electroconvulsive therapy: intractable pain, depression, and bilateral electrode ECT. Pain. 1993;55:393-396.
6. Mandel MR. Electroconvulsive therapy for chronic pain associated with depression. Am J Psychiatry. 1975;132:632-636.
7. Van Hagen K. Chronic intolerable pain. Report of eight cases treated with electric shock. JAMA. 1957; 165:773-777.
8. Pisetsky J. the disappearance of painful phantom limbs after electric shock treatment. Am J Psychiatry. 1946;102:599-601.
9. Janjigian ER. Report of three cases of trigeminal neuralgia apparently cured by electroshock therapy. Am J Psychiatry. 1949;106:143.
10. Weiss DM, Bloomber W, Drew JH. The use of electroshock as therapy for atypical and intractable pain. Trans Am Neurol Assoc. 1957;82:166-168.
11. Hampf G, Kuoppasalmi K, Henricksson M, et al. Chronic pain together with severe depression is responsive to electroconvulsive therapy: a case report. Acta Odontol Scand. 1992;50:129-132.
12. Bebbington PE. Monosymptomatic hypochondriasis, abnormal illness behavior and suicide. Brit J Psychiatry. 1976;128:475-478.
13. Salmon JB, Hanna MH, Williams M, et al. Thalamic pain-the effect of electroconvulsive therapy (ECT). Pain. 1988;33:67-71.
14. Bloomstein JR, Rummans TA, Maruta T, Lin SC, Pilegi TS. The use of electroconvulsive therapy in pain patients. Psychosomatics. 1996;37:374-379.
15. Rasmussen KG, Rummans TA. Electroconvulsive therapy in the management of chronic pain. Curr Pain Headache Rep. 2002;6:17-22.
16. Fukui S, Shigemori S, Yoshimura A, et al. Chronic pain with beneficial response to electroconvulsive therapy and regional cerebral blood flow changes assessed by single photon emission computed tomography. Reg Anesth Pain Med. 2002;27:211-213.
17. Holaday JW, Tortella FC, Meyerhoff JL, et al. Electroconvulsive shock activates endogenous opioid systems: behavioral and biochemical correlates. Ann N YAcad Sci. 1986;467:249-255.
18. Martin JL, Sloviter RS. Focal inhibitory interneuron loss and principal cell hyperexcitability in the rat hippocampus after microinjection of a neurotoxic conjugate of saporin and a peptidase-resistant analog of Substance P. J Comp Neurol. 2001;436:127-152.
19. Madsen TM, Greisen MH Nielsen SM, Bolwig TG, Mikkelsen JD. Electroconvulsive stimuli enhance both neuropeptide Y receptor Y1 and Y2 messenger RNA expression and levels of binding in the rat hippocampus. Neuroscience. 2000;98:33-39.
20. Vezzani A, Hoyer D. Brain somatostatin: a candidate inhibitory role in seizures and epileptogenics. Eur J Neurosci. 1999;11:3767-3776.
21. Yamashita K, Mori A, Otsuki S. Changes in brain thyrotropin-releasing hormone (TRH) of seizure-prone El mice. Exp Neurol. 1990;108:71-75.
22. Baram TZ, Mitchell WG, Brunson K, et al. Infantile spasms: hypothesis-driven therapy and pilot human infant experiments using corticotropin-releasing hormone receptor antagonists. Dev Neurosci. 1999; 21:281-289.
23. Duncan JS. Positron emission tomography receptor studies. Adv Neurol. 1999;79:893-899.
24. Fukui S, Shigemori S, Nosaka S. Changes in regional cerebral blood flow in the thalamus after electroconvulsive therapy for patients with complex regional pain syndrome type 1 (preliminary case series). Reg Anesth Pain Med. 2002;27:529-532.